To determine whether the DDX58 and IFIH1 promoters experience aberrant methylation patterns in EV71-HFMD patients, three groups, including 60 mild and 60 severe cases and 60 healthy controls, were selected for MethylTarget assays. Here, IFIH1 is linked to hand, foot and mouth disease.